Company / Interest Expense
ATOSSA THERAPEUTICS, INC. Interest Expense History
FY2012-FY2014 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$360
FY2014
5-year range
$360 / $18.0K
FY2012-FY2014
Trend
-97.0%
vs FY2013
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $17,992 to $360 over the past 2 years.
Based on SEC 10-K filings.
$360 in FY2014.
Improved from $17,992 to $360 over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2014, interest expense decreased 97.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -15.14 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2016 | - | - |
| FY2015 | - | - |
| FY2014 | $360 | -97.0% |
| FY2013 | $12.0K | -33.1% |
| FY2012 | $18.0K | - |
As of FY2014 · SEC 10-K · Updated Jun 24, 2026